{
  "DOI": "10.1007/s00439-020-02150-6",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-020-02150-6",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eATP-binding cassette (ABC) transporters constitute a superfamily of 48 structurally similar membrane transporters that mediate the ATP-dependent cellular export of a plethora of endogenous and xenobiotic substances. Importantly, genetic variants in \u003cjats:italic\u003eABC\u003c/jats:italic\u003e genes that affect gene function have clinically important effects on drug disposition and can be predictors of the risk of adverse drug reactions and efficacy of chemotherapeutics, calcium channel blockers, and protease inhibitors. Furthermore, loss-of-function of ABC transporters is associated with a variety of congenital disorders. Despite their clinical importance, information about the frequencies and global distribution of functionally relevant \u003cjats:italic\u003eABC\u003c/jats:italic\u003e variants is limited and little is known about the overall genetic complexity of this important gene family. Here, we systematically mapped the genetic landscape of the entire human \u003cjats:italic\u003eABC\u003c/jats:italic\u003e superfamily using Next-Generation Sequencing data from 138,632 individuals across seven major populations. Overall, we identified 62,793 exonic variants, 98.5% of which were rare. By integrating five computational prediction algorithms with structural mapping approaches using experimentally determined crystal structures, we found that the functional \u003cjats:italic\u003eABC\u003c/jats:italic\u003e variability is extensive and highly population-specific. Every individual harbored between 9.3 and 13.9 deleterious \u003cjats:italic\u003eABC\u003c/jats:italic\u003e variants, 76% of which were found only in a single population. Carrier rates of pathogenic variants in \u003cjats:italic\u003eABC\u003c/jats:italic\u003e transporter genes associated with autosomal recessive congenital diseases, such as cystic fibrosis or pseudoxanthoma elasticum, closely mirrored the corresponding population-specific disease prevalence, thus providing a novel resource for rare disease epidemiology. Combined, we provide the most comprehensive, systematic, and consolidated overview of ethnogeographic ABC transporter variability with important implications for personalized medicine, clinical genetics, and precision public health.\u003c/jats:p\u003e",
  "alternative-id": [
    "2150"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "25 December 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "16 March 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "23 March 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "VML is co-founder and shareholder of HepaPredict AB. QX and YZ have no conflicts of interest to declare."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Xiao",
      "given": "Qingyang",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Yitian",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1140-6204",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lauschke",
      "given": "Volker M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        3,
        23
      ]
    ],
    "date-time": "2020-03-23T16:05:01Z",
    "timestamp": 1584979501000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        3,
        23
      ]
    ],
    "date-time": "2021-03-23T00:32:51Z",
    "timestamp": 1616459571000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004543",
      "award": [
        "201600160066"
      ],
      "doi-asserted-by": "publisher",
      "name": "China Scholarship Council"
    },
    {
      "DOI": "10.13039/501100004359",
      "award": [
        "2016-01153",
        "2016-01154"
      ],
      "doi-asserted-by": "publisher",
      "name": "Vetenskapsrådet"
    },
    {
      "DOI": "10.13039/100010661",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "Horizon 2020 Framework Programme"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        8
      ]
    ],
    "date-time": "2024-03-08T04:06:25Z",
    "timestamp": 1709870785345
  },
  "is-referenced-by-count": 31,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2020,
        3,
        23
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2020,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            3,
            23
          ]
        ],
        "date-time": "2020-03-23T00:00:00Z",
        "timestamp": 1584921600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            3,
            23
          ]
        ],
        "date-time": "2020-03-23T00:00:00Z",
        "timestamp": 1584921600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-020-02150-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-020-02150-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-020-02150-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "623-646",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        3,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        3,
        23
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1158/1078-0432.CCR-13-3232",
      "author": "JE Abraham",
      "doi-asserted-by": "publisher",
      "first-page": "2466",
      "journal-title": "Clin Cancer Res",
      "key": "2150_CR1",
      "unstructured": "Abraham JE, Guo Q, Dorling L, Tyrer J, Ingle S, Hardy R, Vallier A-L, Hiller L, Burns R, Jones L, Bowden SJ, Dunn JA, Poole CJ, Caldas C, Pharoah PPD, Earl HM (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel. Clin Cancer Res 20:2466–2475. https://doi.org/10.1158/1078-0432.CCR-13-3232",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "journal-title": "Nat Methods",
      "key": "2150_CR2",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. https://doi.org/10.1038/nmeth0410-248",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s00228-016-2070-9",
      "author": "S Allegra",
      "doi-asserted-by": "publisher",
      "first-page": "1155",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "2150_CR3",
      "unstructured": "Allegra S, Cusato J, De Francia S, Massano D, Piga A, D’Avolio A (2016) Deferasirox AUC efficacy cutoff and role of pharmacogenetics. Eur J Clin Pharmacol 72:1155–1157. https://doi.org/10.1007/s00228-016-2070-9",
      "volume": "72",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gku1205",
      "author": "JS Amberger",
      "doi-asserted-by": "publisher",
      "first-page": "D789",
      "journal-title": "Nucleic Acids Res",
      "key": "2150_CR4",
      "unstructured": "Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A (2015) OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43:D789–D798. https://doi.org/10.1093/nar/gku1205",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1161/CIRCGENETICS.109.898502",
      "author": "KM Bailey",
      "doi-asserted-by": "publisher",
      "first-page": "276",
      "journal-title": "Circ Cardiovasc Genet",
      "key": "2150_CR5",
      "unstructured": "Bailey KM, Romaine SPR, Jackson BM, Farrin AJ, Efthymiou M, Barth JH, Copeland J, McCormack T, Whitehead A, Flather MD, Samani NJ, Nixon J, Hall AS, Balmforth AJ, SPACE ROCKET Trial Group (2010) Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study. Circ Cardiovasc Genet 3:276–285. https://doi.org/10.1161/CIRCGENETICS.109.898502",
      "volume": "3",
      "year": "2010"
    },
    {
      "DOI": "10.2174/1381612822666160810",
      "author": "M Benadiba",
      "doi-asserted-by": "publisher",
      "first-page": "5817",
      "journal-title": "Curr Pharm Des",
      "key": "2150_CR6",
      "unstructured": "Benadiba M, Maor Y (2016) Importance of ABC transporters in drug development. Curr Pharm Des 22:5817–5829. https://doi.org/10.2174/1381612822666160810",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1742-7843.2011.00802.x",
      "author": "TK Bergmann",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "Basic Clin Pharmacol Toxicol",
      "key": "2150_CR7",
      "unstructured": "Bergmann TK, Brasch-Andersen C, Gréen H, Mirza MR, Skougaard K, Wihl J, Keldsen N, Damkier P, Peterson C, Vach W, Brøsen K (2012) Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer. Basic Clin Pharmacol Toxicol 110:199–204. https://doi.org/10.1111/j.1742-7843.2011.00802.x",
      "volume": "110",
      "year": "2012"
    },
    {
      "DOI": "10.1093/nar/28.1.235",
      "author": "HM Berman",
      "doi-asserted-by": "publisher",
      "first-page": "235",
      "journal-title": "Nucleic Acids Res",
      "key": "2150_CR8",
      "unstructured": "Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242",
      "volume": "28",
      "year": "2000"
    },
    {
      "DOI": "10.2165/00129785-200505020-00005",
      "author": "TM Bosch",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Am J Pharmacogenom",
      "key": "2150_CR9",
      "unstructured": "Bosch TM, Kjellberg LM, Bouwers A, Koeleman BPC, Schellens JHM, Beijnen JH, Smits PHM, Meijerman I (2005) Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population. Am J Pharmacogenom 5:123–131",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1002/cpt.1439",
      "author": "DJ Brackman",
      "doi-asserted-by": "publisher",
      "first-page": "623",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR10",
      "unstructured": "Brackman DJ, Yee SW, Enogieru OJ, Shaffer C, Ranatunga D, Denny JC, Wei WQ, Kamatani Y, Kubo M, Roden DM, Jorgenson E, Giacomini KM (2019) Genome-wide association and functional studies reveal novel pharmacological mechanisms for allopurinol. Clin Pharmacol Ther 106:623–631. https://doi.org/10.1002/cpt.1439",
      "volume": "106",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.350",
      "author": "WS Bush",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR11",
      "unstructured": "Bush WS, Crosslin DR, Owusu-Obeng A, Wallace J, Almoguera B, Basford MA, Bielinski SJ, Carrell DS, Connolly JJ, Crawford D, Doheny KF, Gallego CJ, Gordon AS, Keating B, Kirby J, Kitchner T, Manzi S, Mejia AR, Pan V, Perry CL, Peterson JF, Prows CA, Ralston J, Scott SA, Scrol A, Smith M, Stallings SC, Veldhuizen T, Wolf W, Volpi S, Wiley K, Li R, Manolio T, Bottinger E, Brilliant MH, Carey D, Chisholm RL, Chute CG, Haines JL, Hakonarson H, Harley JB, Holm IA, Kullo IJ, Jarvik GP, Larson EB, McCarty CA, Williams MS, Denny JC, Rasmussen-Torvik LJ, Roden DM, Ritchie MD (2016) Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther 100:160–169. https://doi.org/10.1002/cpt.350",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.27567",
      "author": "D Campa",
      "doi-asserted-by": "publisher",
      "first-page": "2920",
      "journal-title": "Int J Cancer",
      "key": "2150_CR12",
      "unstructured": "Campa D, Müller P, Edler L, Knoefel L, Barale R, Heussel CP, Thomas M, Canzian F, Risch A (2012) A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis. Int J Cancer 131:2920–2928. https://doi.org/10.1002/ijc.27567",
      "volume": "131",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0026091",
      "author": "D Caronia",
      "doi-asserted-by": "publisher",
      "first-page": "e26091-6",
      "journal-title": "PLoS ONE",
      "key": "2150_CR13",
      "unstructured": "Caronia D, Patiño-Garcia A, Peréz-Martínez A, Pita G, Moreno LT, Zalacain-Díez M, Molina B, Colmenero I, Sierrasesúmaga L, Benitez J, Gonzalez-Neira A (2011) Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS ONE 6:e26091-6. https://doi.org/10.1371/journal.pone.0026091",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1471-2164-14-S3-S3",
      "author": "H Carter",
      "doi-asserted-by": "publisher",
      "first-page": "S3",
      "issue": "Suppl 3",
      "journal-title": "BMC Genom",
      "key": "2150_CR14",
      "unstructured": "Carter H, Douville C, Stenson PD, Cooper DN, Karchin R (2013) Identifying Mendelian disease genes with the variant effect scoring tool. BMC Genom 14(Suppl 3):S3. https://doi.org/10.1186/1471-2164-14-S3-S3",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.pharmthera.2006.04.009",
      "author": "I Cascorbi",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Pharmacol Ther",
      "key": "2150_CR15",
      "unstructured": "Cascorbi I (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–473. https://doi.org/10.1016/j.pharmthera.2006.04.009",
      "volume": "112",
      "year": "2006"
    },
    {
      "DOI": "10.3892/or_00000633",
      "author": "H Chang",
      "doi-asserted-by": "publisher",
      "first-page": "271",
      "journal-title": "Oncol Rep",
      "key": "2150_CR16",
      "unstructured": "Chang H, Rha SY, Jeung H-C, Im CK, Noh SH, Kim JJ, Chung HC (3435C) Association of the ABCB1 3435C%3eT polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol Rep 23:271–278. https://doi.org/10.3892/or_00000633",
      "volume": "23",
      "year": "2010"
    },
    {
      "DOI": "10.1161/CIRCGENETICS.111.961144",
      "author": "DI Chasman",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Circ Cardiovasc Genet",
      "key": "2150_CR17",
      "unstructured": "Chasman DI, Giulianini F, MacFadyen J, Barratt BJ, Nyberg F, Ridker PM (2012) Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Circ Cardiovasc Genet 5:257–264. https://doi.org/10.1161/CIRCGENETICS.111.961144",
      "volume": "5",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.canep.2013.04.012",
      "author": "P Chaturvedi",
      "doi-asserted-by": "publisher",
      "first-page": "754",
      "journal-title": "Cancer Epidemiol",
      "key": "2150_CR18",
      "unstructured": "Chaturvedi P, Tulsyan S, Agarwal G, Lal P, Agarwal S, Mittal RD, Mittal B (2013) Influence of ABCB1 genetic variants in breast cancer treatment outcomes. Cancer Epidemiol 37:754–761. https://doi.org/10.1016/j.canep.2013.04.012",
      "volume": "37",
      "year": "2013"
    },
    {
      "DOI": "10.1097/FPC.0000000000000168",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "journal-title": "Pharmacogenet Genom",
      "key": "2150_CR19",
      "unstructured": "Chen S, Villeneuve L, Jonker D, Couture F, Laverdière I, Cecchin E, Innocenti F, Toffoli G, Lévesque É, Guillemette C (2015a) ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Pharmacogenet Genom 25:573–583. https://doi.org/10.1097/FPC.0000000000000168",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s12935-015-0191-3",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "journal-title": "Cancer Cell Int",
      "key": "2150_CR20",
      "unstructured": "Chen X, Chen D, Yang S, Ma R, Pan Y, Li X, Ma S (2015b) Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients. Cancer Cell Int 15:43. https://doi.org/10.1186/s12935-015-0191-3",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1002/jcph.165",
      "author": "AVC Coelho",
      "doi-asserted-by": "publisher",
      "first-page": "1286",
      "journal-title": "J Clin Pharmacol",
      "key": "2150_CR21",
      "unstructured": "Coelho AVC, Silva SPS, de Alencar LCA, Stocco G, Crovella S, Brandão LAC, Guimarães RL (2013) ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. J Clin Pharmacol 53:1286–1293. https://doi.org/10.1002/jcph.165",
      "volume": "53",
      "year": "2013"
    },
    {
      "DOI": "10.1038/jhg.2009.132",
      "author": "LMF Costrop",
      "doi-asserted-by": "publisher",
      "first-page": "112",
      "journal-title": "J Hum Genet",
      "key": "2150_CR22",
      "unstructured": "Costrop LMF, Vanakker OOM, Van Laer L, Le Saux O, Martin L, Chassaing N, Guerra D, Pasquali-Ronchetti I, Coucke PJ, De Paepe A (2010) Novel deletions causing pseudoxanthoma elasticum underscore the genomic instability of the ABCC6 region. J Hum Genet 55:112–117. https://doi.org/10.1038/jhg.2009.132",
      "volume": "55",
      "year": "2010"
    },
    {
      "DOI": "10.1093/jnci/djj469",
      "author": "G Cusatis",
      "doi-asserted-by": "publisher",
      "first-page": "1739",
      "journal-title": "J Natl Cancer Inst",
      "key": "2150_CR23",
      "unstructured": "Cusatis G, Gregorc V, Li J, Spreafico A, Ingersoll RG, Verweij J, Ludovini V, Villa E, Hidalgo M, Sparreboom A, Baker SD (2006) Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J Natl Cancer Inst 98:1739–1742. https://doi.org/10.1093/jnci/djj469",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1097/fpc.0b013e328364b6cf",
      "author": "E De Mattia",
      "doi-asserted-by": "publisher",
      "first-page": "549",
      "journal-title": "Pharmacogenet Genom",
      "key": "2150_CR24",
      "unstructured": "De Mattia E, Toffoli G, Polesel J, D’Andrea M, Corona G, Zagonel V, Buonadonna A, Dreussi E, Cecchin E (2013) Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment. Pharmacogenet Genom 23:549–557. https://doi.org/10.1097/fpc.0b013e328364b6cf",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1038/tpj.2009.57",
      "author": "JF Deeken",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR25",
      "unstructured": "Deeken JF, Cormier T, Price DK, Sissung TM, Steinberg SM, Tran K, Liewehr DJ, Dahut WL, Miao X, Figg WD (2009) A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenom J 10:191–199. https://doi.org/10.1038/tpj.2009.57",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pgen.1004333",
      "author": "GM DeStefano",
      "doi-asserted-by": "publisher",
      "first-page": "e1004333",
      "journal-title": "PLoS Genet",
      "key": "2150_CR26",
      "unstructured": "DeStefano GM, Kurban M, Anyane-Yeboa K, Dall’Armi C, Di Paolo G, Feenstra H, Silverberg N, Rohena L, López-Cepeda LD, Jobanputra V, Fantauzzo KA, Kiuru M, Tadin-Strapps M, Sobrino A, Vitebsky A, Warburton D, Levy B, Salas-Alanis JC, Christiano AM (2014) Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowth. PLoS Genet 10:e1004333. https://doi.org/10.1371/journal.pgen.1004333",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1182/blood-2008-03-147744",
      "author": "S Dulucq",
      "doi-asserted-by": "publisher",
      "first-page": "2024",
      "journal-title": "Blood",
      "key": "2150_CR27",
      "unstructured": "Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, Molimard M, Krajinovic M, Mahon F-X (2008) Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood 112:2024–2027. https://doi.org/10.1182/blood-2008-03-147744",
      "volume": "112",
      "year": "2008"
    },
    {
      "DOI": "10.1089/gtmb.2010.0036",
      "author": "SE Flanagan",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "Genet Test Mol Biomark",
      "key": "2150_CR28",
      "unstructured": "Flanagan SE, Patch A-M, Ellard S (2010) Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomark 14:533–537. https://doi.org/10.1089/gtmb.2010.0036",
      "volume": "14",
      "year": "2010"
    },
    {
      "DOI": "10.1097/FPC.0000000000000172",
      "author": "K Fujikura",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "journal-title": "Pharmacogenet Genom",
      "key": "2150_CR29",
      "unstructured": "Fujikura K, Ingelman-Sundberg M, Lauschke VM (2015) Genetic variation in the human cytochrome P450 supergene family. Pharmacogenet Genom 25:584–594. https://doi.org/10.1097/FPC.0000000000000172",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.2133/dmpk.22.48",
      "author": "H Fukushima-Uesaka",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "journal-title": "Drug Metab Pharmacokinet",
      "key": "2150_CR30",
      "unstructured": "Fukushima-Uesaka H, Saito Y, Tohkin M, Maekawa K, Hasegawa R, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Kajio H, Kuzuya N, Yasuda K, Sawada J-i (2007) Genetic variations and haplotype structures of the ABC transporter gene ABCC1 in a Japanese population. Drug Metab Pharmacokinet 22:48–60. https://doi.org/10.2133/dmpk.22.48",
      "volume": "22",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.bbapap.2009.02.014",
      "author": "KL Fung",
      "doi-asserted-by": "publisher",
      "first-page": "860",
      "journal-title": "Biochem Biophys Acta",
      "key": "2150_CR31",
      "unstructured": "Fung KL, Gottesman MM (2009) A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochem Biophys Acta 1794:860–871. https://doi.org/10.1016/j.bbapap.2009.02.014",
      "volume": "1794",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2008.20.8793",
      "author": "DR Gandara",
      "doi-asserted-by": "publisher",
      "first-page": "3540",
      "journal-title": "J Clin Oncol",
      "key": "2150_CR32",
      "unstructured": "Gandara DR, Kawaguchi T, Crowley J, Moon J, Furuse K, Kawahara M, Teramukai S, Ohe Y, Kubota K, Williamson SK, Gautschi O, Lenz H-J, McLeod HL, Lara PN, Coltman CA, Fukuoka M, Saijo N, Fukushima M, Mack PC (2009) Japanese–US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. J Clin Oncol 27:3540–3546. https://doi.org/10.1200/JCO.2008.20.8793",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1111/bcp.13130",
      "author": "G Gervasini",
      "doi-asserted-by": "publisher",
      "first-page": "562",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2150_CR33",
      "unstructured": "Gervasini G, Jara C, Olier C, Romero N, Martínez R, Carrillo JA (2017) Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. Br J Clin Pharmacol 83:562–571. https://doi.org/10.1111/bcp.13130",
      "volume": "83",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs.10.159",
      "author": "E Gonzalez-Haba",
      "doi-asserted-by": "publisher",
      "first-page": "1715",
      "journal-title": "Pharmacogenomics",
      "key": "2150_CR34",
      "unstructured": "Gonzalez-Haba E, García MI, Cortejoso L, López-Lillo C, Barrueco N, García-Alfonso P, Alvarez S, Jiménez JL, Martín ML, Muñóz-Fernández MA, Sanjurjo M, López-Fernández LA (2010) ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. Pharmacogenomics 11:1715–1723. https://doi.org/10.2217/pgs.10.159",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1093/hmg/ddt588",
      "author": "AS Gordon",
      "doi-asserted-by": "publisher",
      "first-page": "1957",
      "journal-title": "Hum Mol Genet",
      "key": "2150_CR35",
      "unstructured": "Gordon AS, Tabor HK, Johnson AD, Snively BM, Assimes TL, Auer PL, Ioannidis JPA, Peters U, Robinson JG, Sucheston LE, Wang D, Sotoodehnia N, Rotter JI, Psaty BM, Jackson RD, Herrington DM, O’Donnell CJ, Reiner AP, Rich SS, Rieder MJ, Bamshad MJ, Nickerson DA, Project NGES (2014) Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset. Hum Mol Genet 23:1957–1963. https://doi.org/10.1093/hmg/ddt588",
      "volume": "23",
      "year": "2014"
    },
    {
      "DOI": "10.1038/tpj.2014.81",
      "author": "J Gregers",
      "doi-asserted-by": "publisher",
      "first-page": "372",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR36",
      "unstructured": "Gregers J, Gréen H, Christensen IJ, Dalhoff K, Schroeder H, Carlsen N, Rosthoej S, Lausen B, Schmiegelow K, Peterson C (2015) Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. Pharmacogenom J 15:372–379. https://doi.org/10.1038/tpj.2014.81",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0442",
      "author": "Y Guo",
      "doi-asserted-by": "publisher",
      "first-page": "1762",
      "journal-title": "Clin Cancer Res",
      "key": "2150_CR37",
      "unstructured": "Guo Y, Köck K, Ritter CA, Chen Z-S, Grube M, Jedlitschky G, Illmer T, Ayres M, Beck JF, Siegmund W, Ehninger G, Gandhi V, Kroemer HK, Kruh GD, Schaich M (2009) Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival. Clin Cancer Res 15:1762–1769. https://doi.org/10.1158/1078-0432.CCR-08-0442",
      "volume": "15",
      "year": "2009"
    },
    {
      "author": "SS Hampras",
      "first-page": "201",
      "journal-title": "Int J Mol Epidemiol Genet",
      "key": "2150_CR38",
      "unstructured": "Hampras SS, Sucheston L, Weiss J, Baer MR, Zirpoli G, Singh PK, Wetzler M, Chennamaneni R, Blanco JG, Ford L, Moysich KB (2010) Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with acute myeloid leukemia. Int J Mol Epidemiol Genet 1:201–207",
      "volume": "1",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.lungcan.2007.12.003",
      "author": "J-Y Han",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "Lung Cancer",
      "key": "2150_CR39",
      "unstructured": "Han J-Y, Lim H-S, Park YH, Lee SY, Lee JS (2009) Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer 63:115–120. https://doi.org/10.1016/j.lungcan.2007.12.003",
      "volume": "63",
      "year": "2009"
    },
    {
      "DOI": "10.4161/cbt.322",
      "author": "Y Honjo",
      "doi-asserted-by": "publisher",
      "first-page": "696",
      "journal-title": "Cancer Biol Ther",
      "key": "2150_CR40",
      "unstructured": "Honjo Y, Morisaki K, Huff LM, Robey RW, Hung J, Dean M, Bates SE (2002) Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1). Cancer Biol Ther 1:696–702",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1023/A:1020433422259",
      "author": "M Horinouchi",
      "doi-asserted-by": "publisher",
      "first-page": "1581",
      "journal-title": "Pharm Res",
      "key": "2150_CR41",
      "unstructured": "Horinouchi M, Sakaeda T, Nakamura T, Morita Y, Tamura T, Aoyama N, Kasuga M, Okumura K (2002) Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm Res 19:1581–1585",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1517/17425255.2011.538383",
      "author": "M Hu",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "2150_CR42",
      "unstructured": "Hu M, To KKW, Mak VWL, Tomlinson B (2011) The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opin Drug Metab Toxicol 7:49–62. https://doi.org/10.1517/17425255.2011.538383",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1111/bcpt.13016",
      "author": "R Hu",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "journal-title": "Basic Clin Pharmacol Toxicol",
      "key": "2150_CR43",
      "unstructured": "Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA (2018) CYP3A5*3 and ABCB1 61A%3eG significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantation. Basic Clin Pharmacol Toxicol 123:320–326. https://doi.org/10.1111/bcpt.13016",
      "volume": "123",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s40246-018-0157-3",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Hum Genom",
      "key": "2150_CR44",
      "unstructured": "Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM (2018) Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum Genom 12:26. https://doi.org/10.1186/s40246-018-0157-3",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ng.3477",
      "author": "I Ionita-Laza",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "journal-title": "Nat Genet",
      "key": "2150_CR45",
      "unstructured": "Ionita-Laza I, McCallum K, Xu B, Buxbaum JD (2016) A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet 48:214–220. https://doi.org/10.1038/ng.3477",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1038/tpj.2015.11",
      "author": "S Jabeen",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR46",
      "unstructured": "Jabeen S, Holmboe L, Alnæs GIG, Andersen AM, Hall KS, Kristensen VN (2015) Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. Pharmacogenom J 15:385–390. https://doi.org/10.1038/tpj.2015.11",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.4161/cbt.18920",
      "author": "M Ji",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "journal-title": "Cancer Biol Ther",
      "key": "2150_CR47",
      "unstructured": "Ji M, Tang J, Zhao J, Xu B, Qin J, Lu J (2012) Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients. Cancer Biol Ther 13:264–271. https://doi.org/10.4161/cbt.18920",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs-2016-0103",
      "author": "Z-P Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Pharmacogenomics",
      "key": "2150_CR48",
      "unstructured": "Jiang Z-P, Zhao X-L, Takahashi N, Angelini S, Dubashi B, Sun L, Xu P (2017) Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis. Pharmacogenomics 18:35–56. https://doi.org/10.2217/pgs-2016-0103",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1124/dmd.104.001800",
      "author": "N Kaniwa",
      "doi-asserted-by": "publisher",
      "first-page": "458",
      "journal-title": "Drug Metab Dispos",
      "key": "2150_CR49",
      "unstructured": "Kaniwa N, Kurose K, Jinno H, Tanaka-Kagawa T, Saito Y, Saeki M, Sawada J-i, Tohkin M, Hasegawa R (2005) Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C%3eT (P229L) found in an African-American. Drug Metab Dispos 33:458–465. https://doi.org/10.1124/dmd.104.001800",
      "volume": "33",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ijc.30026",
      "author": "EJ Kap",
      "doi-asserted-by": "publisher",
      "first-page": "2993",
      "journal-title": "Int J Cancer",
      "key": "2150_CR50",
      "unstructured": "Kap EJ, Seibold P, Scherer D, Habermann N, Balavarca Y, Jansen L, Zucknick M, Becker N, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J (2016) SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients. Int J Cancer 138:2993–3001. https://doi.org/10.1002/ijc.30026",
      "volume": "138",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jdermsci.2005.07.010",
      "author": "E Katona",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "journal-title": "J Dermatol Sci",
      "key": "2150_CR51",
      "unstructured": "Katona E, Aslanidis C, Remenyik E, Csikós M, Kárpáti S, Paragh G, Schmitz G (2005) Identification of a novel deletion in the ABCC6 gene leading to Pseudoxanthoma elasticum. J Dermatol Sci 40:115–121. https://doi.org/10.1016/j.jdermsci.2005.07.010",
      "volume": "40",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nprot.2015.053",
      "author": "LA Kelley",
      "doi-asserted-by": "publisher",
      "first-page": "845",
      "journal-title": "Nat Protoc",
      "key": "2150_CR52",
      "unstructured": "Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10:845–858. https://doi.org/10.1038/nprot.2015.053",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-0145",
      "author": "DHD Kim",
      "doi-asserted-by": "publisher",
      "first-page": "4750",
      "journal-title": "Clin Cancer Res",
      "key": "2150_CR53",
      "unstructured": "Kim DHD, Sriharsha L, Xu W, Kamel-Reid S, Liu X, Siminovitch K, Messner HA, Lipton JH (2009a) Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia. Clin Cancer Res 15:4750–4758. https://doi.org/10.1158/1078-0432.CCR-09-0145",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ygyno.2009.01.002",
      "author": "HS Kim",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "journal-title": "Gynecol Oncol",
      "key": "2150_CR54",
      "unstructured": "Kim HS, Kim M-K, Chung HH, Kim JW, Park NH, Song YS, Kang SB (2009b) Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecol Oncol 113:264–269. https://doi.org/10.1016/j.ygyno.2009.01.002",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.clinthera.2012.06.022",
      "author": "I-W Kim",
      "doi-asserted-by": "publisher",
      "first-page": "1816",
      "journal-title": "Clin Ther",
      "key": "2150_CR55",
      "unstructured": "Kim I-W, Yun H-y, Choi B, Han N, Park S-Y, Lee ES, Oh JM (2012a) ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis. Clin Ther 34:1816–1826. https://doi.org/10.1016/j.clinthera.2012.06.022",
      "volume": "34",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00280-011-1816-4",
      "author": "K-p Kim",
      "doi-asserted-by": "publisher",
      "first-page": "1221",
      "journal-title": "Cancer Chemother Pharmacol",
      "key": "2150_CR56",
      "unstructured": "Kim K-p, Ahn J-H, Kim S-B, Jung KH, Yoon DH, Lee JS, Ahn S-H (2012b) Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol 69:1221–1227. https://doi.org/10.1007/s00280-011-1816-4",
      "volume": "69",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.aar7389",
      "author": "Y Kim",
      "doi-asserted-by": "publisher",
      "first-page": "915",
      "journal-title": "Science",
      "key": "2150_CR57",
      "unstructured": "Kim Y, Chen J (2018) Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science 359:915–919. https://doi.org/10.1126/science.aar7389",
      "volume": "359",
      "year": "2018"
    },
    {
      "DOI": "10.1124/mol.62.1.1",
      "author": "C Kimchi-Sarfaty",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Mol Pharmacol",
      "key": "2150_CR58",
      "unstructured": "Kimchi-Sarfaty C, Gribar JJ, Gottesman MM (2002) Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol 62:1–6. https://doi.org/10.1124/mol.62.1.1",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1126/science.1135308",
      "author": "C Kimchi-Sarfaty",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "journal-title": "Science",
      "key": "2150_CR59",
      "unstructured": "Kimchi-Sarfaty C, Oh JM, Kim I-W, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–528. https://doi.org/10.1126/science.1135308",
      "volume": "315",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2009.25.7246",
      "author": "K Kiyotani",
      "doi-asserted-by": "publisher",
      "first-page": "1287",
      "journal-title": "J Clin Oncol",
      "key": "2150_CR60",
      "unstructured": "Kiyotani K, Mushiroda T, Imamura CK, Hosono N, Tsunoda T, Kubo M, Tanigawara Y, Flockhart DA, Desta Z, Skaar TC, Aki F, Hirata K, Takatsuka Y, Okazaki M, Ohsumi S, Yamakawa T, Sasa M, Nakamura Y, Zembutsu H (2010) Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients. J Clin Oncol 28:1287–1293. https://doi.org/10.1200/JCO.2009.25.7246",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1349-7006.2008.00765.x",
      "author": "K Kiyotani",
      "doi-asserted-by": "publisher",
      "first-page": "967",
      "journal-title": "Cancer Sci",
      "key": "2150_CR61",
      "unstructured": "Kiyotani K, Mushiroda T, Kubo M, Zembutsu H, Sugiyama Y, Nakamura Y (2008) Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Sci 99:967–972. https://doi.org/10.1111/j.1349-7006.2008.00765.x",
      "volume": "99",
      "year": "2008"
    },
    {
      "DOI": "10.1124/pr.113.007518",
      "author": "J König",
      "doi-asserted-by": "publisher",
      "first-page": "944",
      "journal-title": "Pharmacol Rev",
      "key": "2150_CR62",
      "unstructured": "König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65:944–966. https://doi.org/10.1124/pr.113.007518",
      "volume": "65",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2016.33",
      "author": "M Kozyra",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Genet Med",
      "key": "2150_CR63",
      "unstructured": "Kozyra M, Ingelman-Sundberg M, Lauschke VM (2017) Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med 19:20–29. https://doi.org/10.1038/gim.2016.33",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/tpj.2015.63",
      "author": "M Krajinovic",
      "doi-asserted-by": "publisher",
      "first-page": "530",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR64",
      "unstructured": "Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M, Raboisson M-J, Lipshultz SE, Silverman LB, Sallan SE, Neuberg DS, Kutok JL, Laverdiere C, Sinnett D, Andelfinger G (2016) Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. Pharmacogenom J 16:530–535. https://doi.org/10.1038/tpj.2015.63",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejmg.2018.05.020",
      "author": "G Kranenburg",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "Eur J Med Genet",
      "key": "2150_CR65",
      "unstructured": "Kranenburg G, Baas AF, de Jong PA, Asselbergs FW, Visseren FLJ, Spiering W, SMART Study-Group (2019) The prevalence of pseudoxanthoma elasticum: revised estimations based on genotyping in a high vascular risk cohort. Eur J Med Genet 62:90–92. https://doi.org/10.1016/j.ejmg.2018.05.020",
      "volume": "62",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gkt1113",
      "author": "MJ Landrum",
      "doi-asserted-by": "publisher",
      "first-page": "D980",
      "journal-title": "Nucleic Acids Res",
      "key": "2150_CR66",
      "unstructured": "Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42:D980–D985. https://doi.org/10.1093/nar/gkt1113",
      "volume": "42",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cncr.25532",
      "author": "PN Lara",
      "doi-asserted-by": "publisher",
      "first-page": "5710",
      "journal-title": "Cancer",
      "key": "2150_CR67",
      "unstructured": "Lara PN, Chansky K, Shibata T, Fukuda H, Tamura T, Crowley J, Redman MW, Natale R, Saijo N, Gandara DR (2010) Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer 116:5710–5715. https://doi.org/10.1002/cncr.25532",
      "volume": "116",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2008.20.1061",
      "author": "PN Lara",
      "doi-asserted-by": "publisher",
      "first-page": "2530",
      "journal-title": "J Clin Oncol",
      "key": "2150_CR68",
      "unstructured": "Lara PN, Natale R, Crowley J, Lenz H-J, Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR, Chansky K, Gandara DR (2009) Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 27:2530–2535. https://doi.org/10.1200/JCO.2008.20.1061",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.tips.2015.10.006",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Trends Pharmacol Sci",
      "key": "2150_CR69",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M (2016) Precision medicine and rare genetic variants. Trends Pharmacol Sci 37:85–86. https://doi.org/10.1016/j.tips.2015.10.006",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.976",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "745",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR70",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M (2018) How to consider rare genetic variants in personalized drug therapy. Clin Pharmacol Ther 103:745–748. https://doi.org/10.1002/cpt.976",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1097/MIB.0000000000000570",
      "author": "M-N Lee",
      "doi-asserted-by": "publisher",
      "first-page": "2897",
      "journal-title": "Inflamm Bowel Dis",
      "key": "2150_CR71",
      "unstructured": "Lee M-N, Kang B, Choi SY, Kim MJ, Woo SY, Kim J-W, Choe YH, Lee S-Y (2015) Impact of genetic polymorphisms on 6-thioguanine nucleotide levels and toxicity in pediatric patients with IBD treated with azathioprine. Inflamm Bowel Dis 21:2897–2908. https://doi.org/10.1097/MIB.0000000000000570",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "2150_CR72",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won H-H, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Exome Aggregation Consortium (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291. https://doi.org/10.1038/nature19057",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1097/01.fpc.0000197467.21964.67",
      "author": "G Leschziner",
      "doi-asserted-by": "publisher",
      "first-page": "439",
      "journal-title": "Pharmacogenet Genom",
      "key": "2150_CR73",
      "unstructured": "Leschziner G, Zabaneh D, Pirmohamed M, Owen A, Rogers J, Coffey AJ, Balding DJ, Bentley DB, Johnson MR (2006) Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet Genom 16:439–450. https://doi.org/10.1097/01.fpc.0000197467.21964.67",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1093/nar/gky678",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "7793",
      "journal-title": "Nucleic Acids Res",
      "key": "2150_CR74",
      "unstructured": "Li J, Zhao T, Zhang Y, Zhang K, Shi L, Chen Y, Wang X, Sun Z (2018a) Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res 46:7793–7804. https://doi.org/10.1093/nar/gky678",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1038/tpj.2016.75",
      "author": "M Li",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR75",
      "unstructured": "Li M, Seiser EL, Baldwin RM, Ramírez J, Ratain MJ, Innocenti F, Kroetz DL (2018b) ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenom J 18:35–42. https://doi.org/10.1038/tpj.2016.75",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s13238-015-0148-2",
      "author": "Y Liang",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "journal-title": "Protein Cell",
      "key": "2150_CR76",
      "unstructured": "Liang Y, Li S, Chen L (2015) The physiological role of drug transporters. Protein Cell 6:334–350. https://doi.org/10.1007/s13238-015-0148-2",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1164/rccm.200509-1412OC",
      "author": "JJ Lima",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "journal-title": "Am J Respir Crit Care Med",
      "key": "2150_CR77",
      "unstructured": "Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, Wang J, Sylvester J, Holbrook J, Wise R, Weiss ST, Barnes K (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173:379–385. https://doi.org/10.1164/rccm.200509-1412OC",
      "volume": "173",
      "year": "2006"
    },
    {
      "DOI": "10.18632/oncotarget.6953",
      "author": "NV Litviakov",
      "doi-asserted-by": "publisher",
      "first-page": "7829",
      "journal-title": "Oncotarget",
      "key": "2150_CR78",
      "unstructured": "Litviakov NV, Cherdyntseva NV, Tsyganov MM, Slonimskaya EM, Ibragimova MK, Kazantseva PV, Kzhyshkowska J, Choinzonov EL (2016) Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy. Oncotarget 7:7829–7841. https://doi.org/10.18632/oncotarget.6953",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1038/tpj.2016.31",
      "author": "Y Ma",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR79",
      "unstructured": "Ma Y, Xin S, Huang M, Yang Y, Zhu C, Zhao H, Zhang Y, Chen L, Zhao Y, Li J, Zhuang W, Zhu X, Zhang L, Wang X (2017) Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters. Pharmacogenom J 17:325–330. https://doi.org/10.1038/tpj.2016.31",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1093/bioinformatics/btv402",
      "author": "MJ Machiela",
      "doi-asserted-by": "publisher",
      "first-page": "3555",
      "journal-title": "Bioinformatics",
      "key": "2150_CR80",
      "unstructured": "Machiela MJ, Chanock SJ (2015) LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31:3555–3557. https://doi.org/10.1093/bioinformatics/btv402",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.2174/138945011795378504",
      "author": "B Marquez",
      "doi-asserted-by": "publisher",
      "first-page": "600",
      "journal-title": "Curr Drug Targets",
      "key": "2150_CR81",
      "unstructured": "Marquez B, Van Bambeke F (2011) ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets 12:600–620",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1093/jnci/94.15.1160",
      "author": "AD McCollum",
      "doi-asserted-by": "publisher",
      "first-page": "1160",
      "journal-title": "J Natl Cancer Inst",
      "key": "2150_CR82",
      "unstructured": "McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS (2002) Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94:1160–1167",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1371/journal.pone.0076984",
      "author": "CW McDonough",
      "doi-asserted-by": "publisher",
      "first-page": "e76984",
      "journal-title": "PLoS ONE",
      "key": "2150_CR83",
      "unstructured": "McDonough CW, Gillis NK, Alsultan A, Chang S-W, Kawaguchi-Suzuki M, Lang JE, Shahin MHA, Buford TW, El Rouby NM, Sá ACC, Langaee TY, Gums JG, Chapman AB, Cooper-DeHoff RM, Turner ST, Gong Y, Johnson JA (2013) Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. PLoS ONE 8:e76984. https://doi.org/10.1371/journal.pone.0076984",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1080/10428194.2016.1231405",
      "author": "JE Megías-Vericat",
      "doi-asserted-by": "publisher",
      "first-page": "1197",
      "journal-title": "Leuk Lymphoma",
      "key": "2150_CR84",
      "unstructured": "Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Hervás D, Boluda B, García-Robles A, Rodríguez-Veiga R, Martín-Cerezuela M, Cervera J, Sendra L, Sanz J, Miguel A, Lorenzo I, Poveda JL, Sanz MÁ, Aliño SF (2017) Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leuk Lymphoma 58:1197–1206. https://doi.org/10.1080/10428194.2016.1231405",
      "volume": "58",
      "year": "2017"
    },
    {
      "DOI": "10.1097/WNF.0000000000000119",
      "author": "M Moresco",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Clin Neuropharmacol",
      "key": "2150_CR85",
      "unstructured": "Moresco M, Riccardi LN, Pizza F, Zenesini C, Caporali L, Plazzi G, Pelotti S (2016) Pharmacogenetics and treatment response in narcolepsy type 1: relevance of the polymorphisms of the drug transporter gene ABCB1. Clin Neuropharmacol 39:18–23. https://doi.org/10.1097/WNF.0000000000000119",
      "volume": "39",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0086919",
      "author": "JK Mukonzo",
      "doi-asserted-by": "publisher",
      "first-page": "e86919",
      "journal-title": "PLoS ONE",
      "key": "2150_CR86",
      "unstructured": "Mukonzo JK, Owen JS, Ogwal-Okeng J, Kuteesa RB, Nanzigu S, Sewankambo N, Thabane L, Gustafsson LL, Ross C, Aklillu E (2014) Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes. PLoS ONE 9:e86919. https://doi.org/10.1371/journal.pone.0086919",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1101/gr.176601",
      "author": "PC Ng",
      "doi-asserted-by": "publisher",
      "first-page": "863",
      "journal-title": "Genome Res",
      "key": "2150_CR87",
      "unstructured": "Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11:863–874. https://doi.org/10.1101/gr.176601",
      "volume": "11",
      "year": "2001"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-06-0529",
      "author": "T Oguri",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "journal-title": "Mol Cancer Ther",
      "key": "2150_CR88",
      "unstructured": "Oguri T, Bessho Y, Achiwa H, Ozasa H, Maeno K, Maeda H, Sato S, Ueda R (2007) MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 6:122–127. https://doi.org/10.1158/1535-7163.MCT-06-0529",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1186/s13052-015-0161-3",
      "author": "P Pavone",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Ital J Pediatr",
      "key": "2150_CR89",
      "unstructured": "Pavone P, Praticò AD, Falsaperla R, Ruggieri M, Zollino M, Corsello G, Neri G (2015) Congenital generalized hypertrichosis: the skin as a clue to complex malformation syndromes. Ital J Pediatr 41:55. https://doi.org/10.1186/s13052-015-0161-3",
      "volume": "41",
      "year": "2015"
    },
    {
      "DOI": "10.1517/17425255.2011.624513",
      "author": "VH Phan",
      "doi-asserted-by": "publisher",
      "first-page": "1395",
      "journal-title": "Expert Opin Drug Metab Toxicol",
      "key": "2150_CR90",
      "unstructured": "Phan VH, Tan C, Rittau A, Xu H, McLachlan AJ, Clarke SJ (2011) An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. Expert Opin Drug Metab Toxicol 7:1395–1410. https://doi.org/10.1517/17425255.2011.624513",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.3109/00498254.2013.866300",
      "author": "S Pramanik",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "journal-title": "Xenobiotica",
      "key": "2150_CR91",
      "unstructured": "Pramanik S, Surendran ST, Devi S, Krishnamurthi K, Chakrabarti T (2014) Frequency and genotype distribution of ABCB1 gene polymorphisms among Maharashtrian population of Central India. Xenobiotica 44:579–582. https://doi.org/10.3109/00498254.2013.866300",
      "volume": "44",
      "year": "2014"
    },
    {
      "DOI": "10.1038/clpt.2013.80",
      "author": "K Pussegoda",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR92",
      "unstructured": "Pussegoda K, Ross CJ, Visscher H, Yazdanpanah M, Brooks B, Rassekh SR, Zada YF, Dubé M-P, Carleton BC, Hayden MR (2013) Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clin Pharmacol Ther 94:243–251. https://doi.org/10.1038/clpt.2013.80",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1093/nar/gkr407",
      "author": "B Reva",
      "doi-asserted-by": "publisher",
      "first-page": "e118",
      "journal-title": "Nucleic Acids Res",
      "key": "2150_CR93",
      "unstructured": "Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118. https://doi.org/10.1093/nar/gkr407",
      "volume": "39",
      "year": "2011"
    },
    {
      "DOI": "10.1038/tpj.2015.101",
      "author": "RL Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "201",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR94",
      "unstructured": "Roberts RL, Wallace MC, Phipps-Green AJ, Topless R, Drake JM, Tan P, Dalbeth N, Merriman TR, Stamp LK (2017) ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout. Pharmacogenom J 17:201–203. https://doi.org/10.1038/tpj.2015.101",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41568-018-0005-8",
      "author": "RW Robey",
      "doi-asserted-by": "publisher",
      "first-page": "452",
      "journal-title": "Nat Rev Cancer",
      "key": "2150_CR95",
      "unstructured": "Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18:452–464. https://doi.org/10.1038/s41568-018-0005-8",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.trsl.2015.12.011",
      "author": "E Rumiato",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Transl Res",
      "key": "2150_CR96",
      "unstructured": "Rumiato E, Boldrin E, Malacrida S, Battaglia G, Bocus P, Castoro C, Cagol M, Chiarion-Sileni V, Ruol A, Amadori A, Saggioro D (2016) A germline predictive signature of response to platinum chemotherapy in esophageal cancer. Transl Res 171:29–37.e1. https://doi.org/10.1016/j.trsl.2015.12.011",
      "volume": "171",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s100380200018",
      "author": "S Saito",
      "doi-asserted-by": "publisher",
      "first-page": "147",
      "journal-title": "J Hum Genet",
      "key": "2150_CR97",
      "unstructured": "Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y (2002) Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR. J Hum Genet 47:147–171. https://doi.org/10.1007/s100380200018",
      "volume": "47",
      "year": "2002"
    },
    {
      "DOI": "10.1038/gim.2017.156",
      "author": "M Santos",
      "doi-asserted-by": "publisher",
      "first-page": "622",
      "journal-title": "Genet Med",
      "key": "2150_CR98",
      "unstructured": "Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, Rodríguez-Antona C (2018) Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med 20:622–629. https://doi.org/10.1038/gim.2017.156",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1021/bi026626e",
      "author": "ZE Sauna",
      "doi-asserted-by": "publisher",
      "first-page": "13989",
      "journal-title": "Biochemistry",
      "key": "2150_CR99",
      "unstructured": "Sauna ZE, Müller M, Peng X-H, Ambudkar SV (2002) Importance of the conserved walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1). Biochemistry 41:13989–14000. https://doi.org/10.1021/bi026626e",
      "volume": "41",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s00439-019-02081-x",
      "author": "L Schaller",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "journal-title": "Hum Genet",
      "key": "2150_CR100",
      "unstructured": "Schaller L, Lauschke VM (2019) The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet 7:248–319. https://doi.org/10.1007/s00439-019-02081-x",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1042/CBI20110264",
      "author": "AF Semsei",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Cell Biol Int",
      "key": "2150_CR101",
      "unstructured": "Semsei AF, Erdelyi DJ, Ungvari I, Csagoly E, Hegyi MZ, Kiszel PS, Lautner Csorba O, Szabolcs J, Masat P, Fekete G, Falus A, Szalai C, Kovacs GT (2012) ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biol Int 36:79–86. https://doi.org/10.1042/CBI20110264",
      "volume": "36",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s12863-015-0271-3",
      "author": "M Słomka",
      "doi-asserted-by": "publisher",
      "first-page": "114",
      "journal-title": "BMC Genet",
      "key": "2150_CR102",
      "unstructured": "Słomka M, Sobalska-Kwapis M, Korycka-Machała M, Bartosz G, Dziadek J, Strapagiel D (2015) Genetic variation of the ABC transporter gene ABCC1 (multidrug resistance protein 1-MRP1) in the Polish population. BMC Genet 16:114. https://doi.org/10.1186/s12863-015-0271-3",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.clpt.2004.03.003",
      "author": "A Sparreboom",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR103",
      "unstructured": "Sparreboom A, Gelderblom H, Marsh S, Ahluwalia R, Obach R, Principe P, Twelves C, Verweij J, McLeod HL (2004) Diflomotecan pharmacokinetics in relation to ABCG2 421C%3eA genotype. Clin Pharmacol Ther 76:38–44. https://doi.org/10.1016/j.clpt.2004.03.003",
      "volume": "76",
      "year": "2004"
    },
    {
      "DOI": "10.2217/pgs.14.97",
      "author": "S Suthandiram",
      "doi-asserted-by": "publisher",
      "first-page": "1479",
      "journal-title": "Pharmacogenomics",
      "key": "2150_CR104",
      "unstructured": "Suthandiram S, Gan G-G, Zain SM, Bee P-C, Lian L-H, Chang K-M, Ong T-C, Mohamed Z (2014) Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 15:1479–1494. https://doi.org/10.2217/pgs.14.97",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s12253-016-0156-4",
      "author": "M Szczyrek",
      "doi-asserted-by": "publisher",
      "first-page": "607",
      "journal-title": "Pathol Oncol Res",
      "key": "2150_CR105",
      "unstructured": "Szczyrek M, Mlak R, Krawczyk P, Wojas-Krawczyk K, Powrózek T, Szudy-Szczyrek A, Zwolak A, Daniluk J, Milanowski J (2017) Polymorphisms of genes encoding multidrug resistance proteins as a predictive factor for second-line docetaxel therapy in advanced non-small cell lung cancer. Pathol Oncol Res 23:607–614. https://doi.org/10.1007/s12253-016-0156-4",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cncr.25510",
      "author": "M Tanaka",
      "doi-asserted-by": "publisher",
      "first-page": "744",
      "journal-title": "Cancer",
      "key": "2150_CR106",
      "unstructured": "Tanaka M, Okazaki T, Suzuki H, Abbruzzese JL, Li D (2011) Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. Cancer 117:744–751. https://doi.org/10.1002/cncr.25510",
      "volume": "117",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ygyno.2011.11.022",
      "author": "C Tian",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Gynecol Oncol",
      "key": "2150_CR107",
      "unstructured": "Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA (2012) Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 124:575–581. https://doi.org/10.1016/j.ygyno.2011.11.022",
      "volume": "124",
      "year": "2012"
    },
    {
      "DOI": "10.1096/fj.09-129098",
      "author": "Y Toyoda",
      "doi-asserted-by": "publisher",
      "first-page": "2001",
      "journal-title": "FASEB J",
      "key": "2150_CR108",
      "unstructured": "Toyoda Y, Sakurai A, Mitani Y, Nakashima M, Yoshiura K-i, Nakagawa H, Sakai Y, Ota I, Lezhava A, Hayashizaki Y, Niikawa N, Ishikawa T (2009) Earwax, osmidrosis, and breast cancer: why does one SNP (538G%3eA) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J 23:2001–2013. https://doi.org/10.1096/fj.09-129098",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1349-7006.2010.01690.x",
      "author": "T Uemura",
      "doi-asserted-by": "publisher",
      "first-page": "2404",
      "journal-title": "Cancer Sci",
      "key": "2150_CR109",
      "unstructured": "Uemura T, Oguri T, Ozasa H, Takakuwa O, Miyazaki M, Maeno K, Sato S, Ueda R (2010) ABCC11/MRP8 confers pemetrexed resistance in lung cancer. Cancer Sci 101:2404–2410. https://doi.org/10.1111/j.1349-7006.2010.01690.x",
      "volume": "101",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2010.34.3467",
      "author": "H Visscher",
      "doi-asserted-by": "publisher",
      "first-page": "1422",
      "journal-title": "J Clin Oncol",
      "key": "2150_CR110",
      "unstructured": "Visscher H, Ross CJD, Rassekh SR, Barhdadi A, Dubé M-P, Al-Saloos H, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Brown AMK, Rogers PC, Phillips MS, Rieder MJ, Carleton BC, Hayden MR, Canadian Pharmacogenomics Network for Drug Safety Consortium (2012) Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 30:1422–1428. https://doi.org/10.1200/JCO.2010.34.3467",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cpt.89",
      "author": "CC Wen",
      "doi-asserted-by": "publisher",
      "first-page": "518",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR111",
      "unstructured": "Wen CC, Yee SW, Liang X, Hoffmann TJ, Kvale MN, Banda Y, Jorgenson E, Schaefer C, Risch N, Giacomini KM (2015) Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Clin Pharmacol Ther 97:518–525. https://doi.org/10.1002/cpt.89",
      "volume": "97",
      "year": "2015"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.105.576850",
      "author": "L Wojnowski",
      "doi-asserted-by": "publisher",
      "first-page": "3754",
      "journal-title": "Circulation",
      "key": "2150_CR112",
      "unstructured": "Wojnowski L, Kulle B, Schirmer M, Schlüter G, Schmidt A, Rosenberger A, Vonhof S, Bickeböller H, Toliat MR, Suk E-K, Tzvetkov M, Kruger A, Seifert S, Kloess M, Hahn H, Loeffler M, Nürnberg P, Pfreundschuh M, Trümper L, Brockmöller J, Hasenfuss G (2005) NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112:3754–3762. https://doi.org/10.1161/CIRCULATIONAHA.105.576850",
      "volume": "112",
      "year": "2005"
    },
    {
      "DOI": "10.1038/tpj.2011.16",
      "author": "SJ Wolf",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR113",
      "unstructured": "Wolf SJ, Bachtiar M, Wang J, Sim TS, Chong SS, Lee CGL (2011) An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics. Pharmacogenom J 11:315–325. https://doi.org/10.1038/tpj.2011.16",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1038/tpj.2016.77",
      "author": "GEB Wright",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Pharmacogenom J",
      "key": "2150_CR114",
      "unstructured": "Wright GEB, Carleton B, Hayden MR, Ross CJD (2018) The global spectrum of protein-coding pharmacogenomic diversity. Pharmacogenom J 18:187–195. https://doi.org/10.1038/tpj.2016.77",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s00432-012-1209-z",
      "author": "H Wu",
      "doi-asserted-by": "publisher",
      "first-page": "1449",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "2150_CR115",
      "unstructured": "Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X, Lian M, Yao W, Zhao H, Huang D, Sha X, Wang E, Wei M (2012) Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes. J Cancer Res Clin Oncol 138:1449–1462. https://doi.org/10.1007/s00432-012-1209-z",
      "volume": "138",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ijc.32898",
      "author": "Q Xiao",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Cancer",
      "key": "2150_CR116",
      "unstructured": "Xiao Q, Zhou Y, Winter S, Büttner F, Schaeffeler E, Schwab M, Lauschke VM (2020) Germline variant burden in multidrug resistance transporters is a therapy-specific predictor of survival in breast cancer patients. Int J Cancer. https://doi.org/10.1002/ijc.32898",
      "year": "2020"
    },
    {
      "DOI": "10.7314/apjcp.2013.14.8.4595",
      "author": "J Yang",
      "doi-asserted-by": "publisher",
      "first-page": "4595",
      "journal-title": "Asian Pac J Cancer Prev",
      "key": "2150_CR117",
      "unstructured": "Yang J, Wang Z-G, Cai H-Q, Li Y-C, Xu Y-L (2013) Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy. Asian Pac J Cancer Prev 14:4595–4598. https://doi.org/10.7314/apjcp.2013.14.8.4595",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1158/0008-5472.can-3263-2",
      "author": "K Yasui",
      "doi-asserted-by": "publisher",
      "first-page": "1403",
      "journal-title": "Can Res",
      "key": "2150_CR118",
      "unstructured": "Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, Tsuruo T, Inazawa J (2004) Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Can Res 64:1403–1410. https://doi.org/10.1158/0008-5472.can-3263-2",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cpt.1098",
      "author": "SW Yee",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR119",
      "unstructured": "Yee SW, Brackman DJ, Ennis EA, Sugiyama Y, Kamdem LK, Blanchard R, Galetin A, Zhang L, Giacomini KM (2018) Influence of transporter polymorphisms on drug disposition and response: a perspective from the International Transporter Consortium. Clin Pharmacol Ther 104:803–817. https://doi.org/10.1002/cpt.1098",
      "volume": "104",
      "year": "2018"
    },
    {
      "DOI": "10.1038/jhg.2013.38",
      "author": "SW Yee",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "journal-title": "J Hum Genet",
      "key": "2150_CR120",
      "unstructured": "Yee SW, Mefford JA, Singh N, Percival M-E, Stecula A, Yang K, Witte JS, Takahashi A, Kubo M, Matsuda K, Giacomini KM, Andreadis C (2013) Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. J Hum Genet 58:353–361. https://doi.org/10.1038/jhg.2013.38",
      "volume": "58",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.phrs.2018.10.017",
      "author": "B Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "Pharmacol Res",
      "key": "2150_CR121",
      "unstructured": "Zhang B, Lauschke VM (2019) Genetic variability and population diversity of the human SLCO (OATP) transporter family. Pharmacol Res 139:550–559. https://doi.org/10.1016/j.phrs.2018.10.017",
      "volume": "139",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.1214",
      "author": "L Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "793",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR122",
      "unstructured": "Zhang L, Huang S-M, Reynolds K, Madabushi R, Zineh I (2018) Transporters in drug development: scientific and regulatory considerations. Clin Pharmacol Ther 104:793–796. https://doi.org/10.1002/cpt.1214",
      "volume": "104",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.690",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2150_CR123",
      "unstructured": "Zhou Y, Ingelman-Sundberg M, Lauschke VM (2017) Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther 102:688–700. https://doi.org/10.1002/cpt.690",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105429",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "617",
      "journal-title": "J Med Genet",
      "key": "2150_CR124",
      "unstructured": "Zhou Y, Lauschke VM (2018) Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews. J Med Genet 55:617–627. https://doi.org/10.1136/jmedgenet-2018-105429",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1096/fj.13-245639",
      "author": "JK Zolnerciks",
      "doi-asserted-by": "publisher",
      "first-page": "4335",
      "journal-title": "FASEB J",
      "key": "2150_CR125",
      "unstructured": "Zolnerciks JK, Akkaya BG, Snippe M, Chiba P, Seelig A, Linton KJ (2014) The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle. FASEB J 28:4335–4346. https://doi.org/10.1096/fj.13-245639",
      "volume": "28",
      "year": "2014"
    }
  ],
  "reference-count": 125,
  "references-count": 125,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-020-02150-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Ethnogeographic and inter-individual variability of human ABC transporters"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "139"
}